<p class="title">The initial public offer of Shalby Ltd, Ahmedabad-based multi-specialty hospital chain, was subscribed 20 per cent on the first day of the three-day bidding today.</p>.<p class="bodytext">The IPO, which aims to raise Rs 504 crore, received bids for over 29.32 lakh shares against the total issue size of more than 1.45 crore scrips, indicating a subscription of 20 per cent, data available with National Stock Exchange (NSE) showed.</p>.<p class="bodytext">The initial share sale of Shalby will be open for public subscriptions till December 7.</p>.<p class="bodytext">Shalby, yesterday, raised over Rs 150 crore from anchor investors.</p>.<p class="bodytext">The IPO comprises a fresh issue of equity shares aggregating up to Rs 480 crore and an offer for sale of up to 10 lakh equity shares by the selling shareholder.</p>.<p class="bodytext">The price band has been fixed at Rs 245-248 per share. At the upper end, the public issue would fetch Rs 504 crore.</p>.<p class="bodytext">Proceeds of the IPO will be utilised towards repayment of borrowings availed by the company besides purchasing medical equipment for existing, recently set-up as well as upcoming hospitals.</p>.<p class="bodytext">In the recent months, healthcare services firms Alkem Laboratories, Dr Lal Pathlabs, Narayana Hrudayalaya, Thyrocare and Eris Lifesciences have tapped the primary market through IPO route. </p>
<p class="title">The initial public offer of Shalby Ltd, Ahmedabad-based multi-specialty hospital chain, was subscribed 20 per cent on the first day of the three-day bidding today.</p>.<p class="bodytext">The IPO, which aims to raise Rs 504 crore, received bids for over 29.32 lakh shares against the total issue size of more than 1.45 crore scrips, indicating a subscription of 20 per cent, data available with National Stock Exchange (NSE) showed.</p>.<p class="bodytext">The initial share sale of Shalby will be open for public subscriptions till December 7.</p>.<p class="bodytext">Shalby, yesterday, raised over Rs 150 crore from anchor investors.</p>.<p class="bodytext">The IPO comprises a fresh issue of equity shares aggregating up to Rs 480 crore and an offer for sale of up to 10 lakh equity shares by the selling shareholder.</p>.<p class="bodytext">The price band has been fixed at Rs 245-248 per share. At the upper end, the public issue would fetch Rs 504 crore.</p>.<p class="bodytext">Proceeds of the IPO will be utilised towards repayment of borrowings availed by the company besides purchasing medical equipment for existing, recently set-up as well as upcoming hospitals.</p>.<p class="bodytext">In the recent months, healthcare services firms Alkem Laboratories, Dr Lal Pathlabs, Narayana Hrudayalaya, Thyrocare and Eris Lifesciences have tapped the primary market through IPO route. </p>